In the in-house ESCC cohort (<i>n</i> = 14), <i>NLRX1</i> was verified as a reliable prognostic factor for disease-free survival (<i>p</i> = 0.043). The gene discussed is NLRX1; the disease is esophageal squamous cell carcinoma.